+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Infectious Disease Immunoassay Testing Market Size, Share & Trends Analysis Report by Disease Type, Technology, Test Type, End Use, Region, and Segment Forecasts, 2026-2033- Product Image
Infectious Disease Immunoassay Testing Market Size, Share & Trends Analysis Report by Disease Type, Technology, Test Type, End Use, Region, and Segment Forecasts, 2026-2033- Product Image
New

Infectious Disease Immunoassay Testing Market Size, Share & Trends Analysis Report by Disease Type, Technology, Test Type, End Use, Region, and Segment Forecasts, 2026-2033

  • PDF Icon

    Report

  • 150 Pages
  • May 2026
  • Region: Global
  • Grand View Research
  • ID: 6246068
REQUEST CUSTOMIZATION
Description Jump to:
The global infectious disease immunoassay testing market size was estimated at USD 8.89 billion in 2025 and is projected to grow from USD 9.12 billion in 2026 to USD 12.03 billion by 2033, at a CAGR of 4.02% from 2026 to 2033. North America dominated the global infectious disease immunoassay testing market with the largest revenue share of 47.75% in 2025.

Market Dynamics

Drivers: Rising Prevalence of Infectious Diseases

The increasing burden of infectious diseases remains a significant factor supporting the market growth. The rising incidence of viral, bacterial, fungal, and parasitic infections continues to drive demand for rapid, accurate immunoassay-based diagnostic and serological testing solutions across healthcare settings globally. According to the World Health Organization, approximately 10.7 million people developed tuberculosis globally in 2024, while nearly 1.23 million tuberculosis-related deaths were reported during the year. Moreover, UNAIDS estimated that around 40.08 million people were living with HIV globally in 2025. The growing burden of chronic infectious diseases is driving greater adoption of ELISA, CLIA, rapid antigen tests, and combined antigen/antibody immunoassay technologies across hospitals, diagnostic laboratories, blood banks, and public health screening programs. This has further resulted in the continuous growth of immunoassay infectious diagnostics market.

Respiratory infectious diseases continue to account for a substantial share of global infectious disease testing volumes. According to the U.S. Centers for Disease Control and Prevention (CDC), influenza activity continued to increase across the United States during the 2025 respiratory virus season, with influenza infections growing or likely growing in 47 states as of December 2025. In addition, RSV infections were reported to be growing or likely growing in 32 states, particularly among children aged 0-4 years, while COVID-19 infections were increasing across 31 states. The continued circulation of influenza, RSV, and COVID-19 is generating significant seasonal demand for immunoassay-based infectious disease testing across healthcare settings. The rising prevalence of respiratory viral infections is accelerating the adoption of rapid antigen tests, fluorescent immunoassays, and chemiluminescence immunoassay (CLIA) systems across hospitals, physician offices, and diagnostic laboratories. The increasing focus on early disease detection, respiratory infection surveillance, and outbreak management is further supporting the global growth of the infectious disease immunoassay testing industry.

Sexually transmitted infections and vector-borne diseases are also contributing to the market growth. The WHO estimated that more than 1 million curable sexually transmitted infections are acquired every day globally, including syphilis, gonorrhea, chlamydia, and trichomoniasis. Rising STI prevalence and increasing burden of infections such as HSV-2 and syphilis are strengthening demand for antibody testing and combined antigen/antibody immunoassays across diagnostic laboratories, blood banks, and public health agencies. In addition, increasing dengue outbreaks across the Asia-Pacific and Latin America are supporting the adoption of multiplex immunoassays and rapid antigen testing solutions. At the same time, the expansion of infectious disease screening programs continues to increase global immunoassay testing volumes.

Global Infectious Disease Immunoassay Testing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global infectious disease immunoassay testing market report based on disease type, technology, test type, technology, and region:

Disease Type Outlook (Revenue, USD Million, 2021-2033)

  • Viral infections
  • Bacterial infections
  • Fungal infections
  • Parasitic infections

Technology Outlook (Revenue, USD Million, 2021-2033)

  • ELISA
  • CLIA
  • Rapid antigen tests
  • Fluorescent immunoassay
  • Multiplex immunoassay

Test Type Outlook (Revenue, USD Million, 2021-2033)

  • Antigen testing
  • Antibody testing
  • Combined Ag/Ab tests
  • Toxin assays

End Use Outlook (Revenue, USD Million, 2021-2033)

  • Hospitals
  • Diagnostic labs
  • Physician offices
  • Blood banks
  • Public health agencies

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Disease Type
1.2.2. Technology
1.2.3. Test Type
1.2.4. End use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Infectious Disease Immunoassay Testing Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
3.3.3. Pipeline Analysis
3.3.4. Patent Expiry Analysis
3.3.5. Pricing Analysis
Chapter 4. Infectious Disease Immunoassay Testing Market: Disease Type Business Analysis
4.1. Disease Type Market Share, 2025 & 2033
4.2. Disease Type Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Disease Type, 2021 to 2033 (USD Million)
4.4. Viral infections
4.4.1. Viral infections Market, 2021 - 2033 (USD Million)
4.5. Bacterial infections
4.5.1. Bacterial infections Market, 2021 - 2033 (USD Million)
4.6. Fungal infections
4.6.1. Fungal infections Market, 2021 - 2033 (USD Million)
4.7. Parasitic infections
4.7.1. Parasitic infections Market, 2021 - 2033 (USD Million)
Chapter 5. Infectious Disease Immunoassay Testing Market: Technology Business Analysis
5.1. Technology Market Share, 2025 & 2033
5.2. Technology Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Technology, 2021 to 2033 (USD Million)
5.4. ELISA
5.4.1. ELISA Market, 2021 - 2033 (USD Million)
5.5. CLIA
5.5.1. CLIA Market, 2021 - 2033 (USD Million)
5.6. Rapid antigen tests
5.6.1. Rapid antigen tests Market, 2021 - 2033 (USD Million)
5.7. Fluorescent immunoassay
5.7.1. Fluorescent immunoassay Market, 2021 - 2033 (USD Million)
5.8. Multiplex immunoassay
5.8.1. Multiplex immunoassay Market, 2021 - 2033 (USD Million)
Chapter 6. Infectious Disease Immunoassay Testing Market: Test Type Business Analysis
6.1. Test Type Market Share, 2025 & 2033
6.2. Test Type Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Test Type, 2021 to 2033 (USD Million)
6.4. Antigen testing
6.4.1. Antigen testing Market, 2021 - 2033 (USD Million)
6.5. Antibody testing
6.5.1. Antibody testing Market, 2021 - 2033 (USD Million)
6.6. Combined Ag/Ab tests
6.6.1. Combined Ag/Ab tests Market, 2021 - 2033 (USD Million)
6.7. Toxin assays
6.7.1. Toxin assays Market, 2021 - 2033 (USD Million)
Chapter 7. Infectious Disease Immunoassay Testing Market: End Use Business Analysis
7.1. End Use Market Share, 2025 & 2033
7.2. End Use Segment Dashboard
7.3. Market Size & Forecasts and Trend Analysis, By End Use, 2021 to 2033 (USD Million)
7.4. Hospitals
7.4.1. Hospitals Market, 2021 - 2033 (USD Million)
7.5. Diagnostic labs
7.5.1. Diagnostic labs Market, 2021 - 2033 (USD Million)
7.6. Physician offices
7.6.1. Physician offices Market, 2021 - 2033 (USD Million)
7.7. Blood banks
7.7.1. Blood banks Market, 2021 - 2033 (USD Million)
7.8. Public health agencies
7.8.1. Public health agencies Market, 2021 - 2033 (USD Million)
Chapter 8. Infectious Disease Immunoassay Testing Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2025 & 2033
8.2. Regional Market Dashboard
8.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
8.4. North America
8.4.1. North America Infectious Disease Immunoassay Testing Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
8.4.2. U.S.
8.4.2.1. Key Country Dynamics
8.4.2.2. Target Disease Prevalence
8.4.2.3. Regulatory Framework
8.4.2.4. Reimbursement Framework
8.4.2.5. U.S. Infectious Disease Immunoassay Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.4.3. Canada
8.4.3.1. Key Country Dynamics
8.4.3.2. Target Disease Prevalence
8.4.3.3. Regulatory Framework
8.4.3.4. Reimbursement Framework
8.4.3.5. Canada Infectious Disease Immunoassay Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.4.4. Mexico
8.4.4.1. Key Country Dynamics
8.4.4.2. Target Disease Prevalence
8.4.4.3. Regulatory Framework
8.4.4.4. Reimbursement Framework
8.4.4.5. Mexico Infectious Disease Immunoassay Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5. Europe
8.5.1. Europe Infectious Disease Immunoassay Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.2. UK
8.5.2.1. Key Country Dynamics
8.5.2.2. Target Disease Prevalence
8.5.2.3. Regulatory Framework
8.5.2.4. Reimbursement Framework
8.5.2.5. UK Infectious Disease Immunoassay Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.3. Germany
8.5.3.1. Key Country Dynamics
8.5.3.2. Target Disease Prevalence
8.5.3.3. Regulatory Framework
8.5.3.4. Reimbursement Framework
8.5.3.5. Germany Infectious Disease Immunoassay Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.4. France
8.5.4.1. Key Country Dynamics
8.5.4.2. Target Disease Prevalence
8.5.4.3. Regulatory Framework
8.5.4.4. Reimbursement Framework
8.5.4.5. France Infectious Disease Immunoassay Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.5. Italy
8.5.5.1. Key Country Dynamics
8.5.5.2. Target Disease Prevalence
8.5.5.3. Regulatory Framework
8.5.5.4. Reimbursement Framework
8.5.5.5. Italy Infectious Disease Immunoassay Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.6. Spain
8.5.6.1. Key Country Dynamics
8.5.6.2. Target Disease Prevalence
8.5.6.3. Regulatory Framework
8.5.6.4. Reimbursement Framework
8.5.6.5. Spain Infectious Disease Immunoassay Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.7. Denmark
8.5.7.1. Key Country Dynamics
8.5.7.2. Target Disease Prevalence
8.5.7.3. Regulatory Framework
8.5.7.4. Reimbursement Framework
8.5.7.5. Denmark Infectious Disease Immunoassay Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.8. Sweden
8.5.8.1. Key Country Dynamics
8.5.8.2. Target Disease Prevalence
8.5.8.3. Regulatory Framework
8.5.8.4. Reimbursement Framework
8.5.8.5. Sweden Infectious Disease Immunoassay Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.5.9. Norway
8.5.9.1. Key Country Dynamics
8.5.9.2. Target Disease Prevalence
8.5.9.3. Regulatory Framework
8.5.9.4. Reimbursement Framework
8.5.9.5. Norway Infectious Disease Immunoassay Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6. Asia Pacific
8.6.1. Asia Pacific Infectious Disease Immunoassay Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6.2. Japan
8.6.2.1. Key Country Dynamics
8.6.2.2. Target Disease Prevalence
8.6.2.3. Regulatory Framework
8.6.2.4. Reimbursement Framework
8.6.2.5. Japan Infectious Disease Immunoassay Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6.3. China
8.6.3.1. Key Country Dynamics
8.6.3.2. Target Disease Prevalence
8.6.3.3. Regulatory Framework
8.6.3.4. Reimbursement Framework
8.6.3.5. China Infectious Disease Immunoassay Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6.4. India
8.6.4.1. Key Country Dynamics
8.6.4.2. Target Disease Prevalence
8.6.4.3. Regulatory Framework
8.6.4.4. Reimbursement Framework
8.6.4.5. India Infectious Disease Immunoassay Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6.5. Australia
8.6.5.1. Key Country Dynamics
8.6.5.2. Target Disease Prevalence
8.6.5.3. Regulatory Framework
8.6.5.4. Reimbursement Framework
8.6.5.5. Australia Infectious Disease Immunoassay Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6.6. South Korea
8.6.6.1. Key Country Dynamics
8.6.6.2. Target Disease Prevalence
8.6.6.3. Regulatory Framework
8.6.6.4. Reimbursement Framework
8.6.6.5. South Korea Infectious Disease Immunoassay Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.6.7. Thailand
8.6.7.1. Key Country Dynamics
8.6.7.2. Target Disease Prevalence
8.6.7.3. Regulatory Framework
8.6.7.4. Reimbursement Framework
8.6.7.5. Thailand Infectious Disease Immunoassay Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.7. Latin America
8.7.1. Latin America Infectious Disease Immunoassay Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.7.2. Brazil
8.7.2.1. Key Country Dynamics
8.7.2.2. Target Disease Prevalence
8.7.2.3. Regulatory Framework
8.7.2.4. Reimbursement Framework
8.7.2.5. Brazil Infectious Disease Immunoassay Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.7.3. Argentina
8.7.3.1. Key Country Dynamics
8.7.3.2. Target Disease Prevalence
8.7.3.3. Regulatory Framework
8.7.3.4. Reimbursement Framework
8.7.3.5. Argentina Infectious Disease Immunoassay Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.8. Middle East and Africa
8.8.1. Middle East and Africa Infectious Disease Immunoassay Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.8.2. South Africa
8.8.2.1. Key Country Dynamics
8.8.2.2. Target Disease Prevalence
8.8.2.3. Regulatory Framework
8.8.2.4. Reimbursement Framework
8.8.2.5. South Africa Infectious Disease Immunoassay Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.8.3. Saudi Arabia
8.8.3.1. Key Country Dynamics
8.8.3.2. Target Disease Prevalence
8.8.3.3. Regulatory Framework
8.8.3.4. Reimbursement Framework
8.8.3.5. Saudi Arabia Infectious Disease Immunoassay Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.8.4. UAE
8.8.4.1. Key Country Dynamics
8.8.4.2. Target Disease Prevalence
8.8.4.3. Regulatory Framework
8.8.4.4. Reimbursement Framework
8.8.4.5. UAE Infectious Disease Immunoassay Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
8.8.5. Kuwait
8.8.5.1. Key Country Dynamics
8.8.5.2. Target Disease Prevalence
8.8.5.3. Regulatory Framework
8.8.5.4. Reimbursement Framework
8.8.5.5. Kuwait Infectious Disease Immunoassay Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Participant Overview
9.2. Company Market Position Analysis
9.3. Company Categorization
9.4. Strategy Mapping
9.5. Company Profiles/Listing
9.5.1. Abbott
9.5.1.1. Overview
9.5.1.2. Financial Performance
9.5.1.3. Product Benchmarking
9.5.1.4. Strategic Initiatives
9.5.2. Siemens Healthineers
9.5.2.1. Overview
9.5.2.2. Financial Performance
9.5.2.3. Product Benchmarking
9.5.2.4. Strategic Initiatives
9.5.3. Danaher Corporation
9.5.3.1. Overview
9.5.3.2. Financial Performance
9.5.3.3. Product Benchmarking
9.5.3.4. Strategic Initiatives
9.5.4. bioMerieux SA
9.5.4.1. Overview
9.5.4.2. Financial Performance
9.5.4.3. Product Benchmarking
9.5.4.4. Strategic Initiatives
9.5.5. Quidel Corporation
9.5.5.1. Overview
9.5.5.2. Financial Performance
9.5.5.3. Product Benchmarking
9.5.5.4. Strategic Initiatives
9.5.6. Ortho Clinical Diagnostics
9.5.6.1. Overview
9.5.6.2. Financial Performance
9.5.6.3. Product Benchmarking
9.5.6.4. Strategic Initiatives
9.5.7. Sysmex Corporation
9.5.7.1. Overview
9.5.7.2. Financial Performance
9.5.7.3. Product Benchmarking
9.5.7.4. Strategic Initiatives
9.5.8. Bio-Rad Laboratories, Inc.
9.5.8.1. Overview
9.5.8.2. Financial Performance
9.5.8.3. Product Benchmarking
9.5.8.4. Strategic Initiatives
9.5.9. F. Hoffmann-La Roche AG
9.5.9.1. Overview
9.5.9.2. Financial Performance
9.5.9.3. Product Benchmarking
9.5.9.4. Strategic Initiatives
9.5.10. Becton, Dickinson, and Company
9.5.10.1. Overview
9.5.10.2. Financial Performance
9.5.10.3. Product Benchmarking
9.5.10.4. Strategic Initiatives
9.5.11. Thermo Fisher Scientific, Inc.
9.5.11.1. Overview
9.5.11.2. Financial Performance
9.5.11.3. Product Benchmarking
9.5.11.4. Strategic Initiatives
List of Tables
Table 1. List Of Secondary Sources
Table 2. List Of Abbreviations
Table 3. Global Infectious Disease Immunoassay Testing Market, By Region, 2021 - 2033 (USD Million)
Table 4. Global Infectious Disease Immunoassay Testing Market, By Disease Type, 2021 - 2033 (USD Million)
Table 5. Global Infectious Disease Immunoassay Testing Market, By Technology, 2021 - 2033 (USD Million)
Table 6. Global Infectious Disease Immunoassay Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 7. Global Infectious Disease Immunoassay Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 8. North America Infectious Disease Immunoassay Testing Market, By Country, 2021 - 2033 (USD Million)
Table 9. North America Infectious Disease Immunoassay Testing Market, By Disease Type, 2021 - 2033 (USD Million)
Table 10. North America Infectious Disease Immunoassay Testing Market, By Technology, 2021 - 2033 (USD Million)
Table 11. North America Infectious Disease Immunoassay Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 12. North America Infectious Disease Immunoassay Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 13. U.S. Infectious Disease Immunoassay Testing Market, By Disease Type, 2021 - 2033 (USD Million)
Table 14. U.S. Infectious Disease Immunoassay Testing Market, By Technology, 2021 - 2033 (USD Million)
Table 15. U.S. Infectious Disease Immunoassay Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 16. U.S. Infectious Disease Immunoassay Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 17. Canada Infectious Disease Immunoassay Testing Market, By Disease Type, 2021 - 2033 (USD Million)
Table 18. Canada Infectious Disease Immunoassay Testing Market, By Technology, 2021 - 2033 (USD Million)
Table 19. Canada Infectious Disease Immunoassay Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 20. Canada Infectious Disease Immunoassay Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 21. Mexico Infectious Disease Immunoassay Testing Market, By Disease Type, 2021 - 2033 (USD Million)
Table 22. Mexico Infectious Disease Immunoassay Testing Market, By Technology, 2021 - 2033 (USD Million)
Table 23. Mexico Infectious Disease Immunoassay Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 24. Mexico Infectious Disease Immunoassay Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 25. Europe Infectious Disease Immunoassay Testing Market, By Country, 2021 - 2033 (USD Million)
Table 26. Europe Infectious Disease Immunoassay Testing Market, By Disease Type, 2021 - 2033 (USD Million)
Table 27. Europe Infectious Disease Immunoassay Testing Market, By Technology, 2021 - 2033 (USD Million)
Table 28. Europe Infectious Disease Immunoassay Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 29. Europe Infectious Disease Immunoassay Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 30. UK Infectious Disease Immunoassay Testing Market, By Disease Type, 2021 - 2033 (USD Million)
Table 31. UK Infectious Disease Immunoassay Testing Market, By Technology, 2021 - 2033 (USD Million)
Table 32. UK Infectious Disease Immunoassay Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 33. UK Infectious Disease Immunoassay Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 34. Germany Infectious Disease Immunoassay Testing Market, By Disease Type, 2021 - 2033 (USD Million)
Table 35. Germany Infectious Disease Immunoassay Testing Market, By Technology, 2021 - 2033 (USD Million)
Table 36. Germany Infectious Disease Immunoassay Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 37. Germany Infectious Disease Immunoassay Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 38. France Infectious Disease Immunoassay Testing Market, By Disease Type, 2021 - 2033 (USD Million)
Table 39. France Infectious Disease Immunoassay Testing Market, By Technology, 2021 - 2033 (USD Million)
Table 40. France Infectious Disease Immunoassay Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 41. France Infectious Disease Immunoassay Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 42. Italy Infectious Disease Immunoassay Testing Market, By Disease Type, 2021 - 2033 (USD Million)
Table 43. Italy Infectious Disease Immunoassay Testing Market, By Technology, 2021 - 2033 (USD Million)
Table 44. Italy Infectious Disease Immunoassay Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 45. Italy Infectious Disease Immunoassay Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 46. Spain Infectious Disease Immunoassay Testing Market, By Disease Type, 2021 - 2033 (USD Million)
Table 47. Spain Infectious Disease Immunoassay Testing Market, By Technology, 2021 - 2033 (USD Million)
Table 48. Spain Infectious Disease Immunoassay Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 49. Spain Infectious Disease Immunoassay Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 50. Norway Infectious Disease Immunoassay Testing Market, By Disease Type, 2021 - 2033 (USD Million)
Table 51. Norway Infectious Disease Immunoassay Testing Market, By Technology, 2021 - 2033 (USD Million)
Table 52. Norway Infectious Disease Immunoassay Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 53. Norway Infectious Disease Immunoassay Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 54. Denmark Infectious Disease Immunoassay Testing Market, By Disease Type, 2021 - 2033 (USD Million)
Table 55. Denmark Infectious Disease Immunoassay Testing Market, By Technology, 2021 - 2033 (USD Million)
Table 56. Denmark Infectious Disease Immunoassay Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 57. Denmark Infectious Disease Immunoassay Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 58. Sweden Infectious Disease Immunoassay Testing Market, By Disease Type, 2021 - 2033 (USD Million)
Table 59. Sweden Infectious Disease Immunoassay Testing Market, By Technology, 2021 - 2033 (USD Million)
Table 60. Sweden Infectious Disease Immunoassay Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 61. Sweden Infectious Disease Immunoassay Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 62. Asia Pacific Infectious Disease Immunoassay Testing Market, By Country, 2021 - 2033 (USD Million)
Table 63. Asia Pacific Infectious Disease Immunoassay Testing Market, By Disease Type, 2021 - 2033 (USD Million)
Table 64. Asia Pacific Infectious Disease Immunoassay Testing Market, By Technology, 2021 - 2033 (USD Million)
Table 65. Asia Pacific Infectious Disease Immunoassay Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 66. Asia Pacific Infectious Disease Immunoassay Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 67. Japan Infectious Disease Immunoassay Testing Market, By Disease Type, 2021 - 2033 (USD Million)
Table 68. Japan Infectious Disease Immunoassay Testing Market, By Technology, 2021 - 2033 (USD Million)
Table 69. Japan Infectious Disease Immunoassay Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 70. Japan Infectious Disease Immunoassay Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 71. China Infectious Disease Immunoassay Testing Market, By Disease Type, 2021 - 2033 (USD Million)
Table 72. China Infectious Disease Immunoassay Testing Market, By Technology, 2021 - 2033 (USD Million)
Table 73. China Infectious Disease Immunoassay Testing Market, By Test Type, 2021 - 2033 (USD Million
Table 74. China Infectious Disease Immunoassay Testing Market, By End Use, 2021 - 2033 (USD Million))
Table 75. India Infectious Disease Immunoassay Testing Market, By Disease Type, 2021 - 2033 (USD Million)
Table 76. India Infectious Disease Immunoassay Testing Market, By Technology, 2021 - 2033 (USD Million)
Table 77. India Infectious Disease Immunoassay Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 78. India Infectious Disease Immunoassay Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 79. Australia Infectious Disease Immunoassay Testing Market, By Disease Type, 2021 - 2033 (USD Million)
Table 80. Australia Infectious Disease Immunoassay Testing Market, By Technology, 2021 - 2033 (USD Million)
Table 81. Australia Infectious Disease Immunoassay Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 82. Australia Infectious Disease Immunoassay Testing Market, By End Use 2021 - 2033 (USD Million)
Table 83. South Korea Infectious Disease Immunoassay Testing Market, By Disease Type, 2021 - 2033 (USD Million)
Table 84. South Korea Infectious Disease Immunoassay Testing Market, By Technology, 2021 - 2033 (USD Million)
Table 85. South Korea Infectious Disease Immunoassay Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 86. South Korea Infectious Disease Immunoassay Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 87. Thailand Infectious Disease Immunoassay Testing Market, By Disease Type, 2021 - 2033 (USD Million)
Table 88. Thailand Infectious Disease Immunoassay Testing Market, By Technology, 2021 - 2033 (USD Million)
Table 89. Thailand Infectious Disease Immunoassay Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 90. Thailand Infectious Disease Immunoassay Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 91. Latin America Infectious Disease Immunoassay Testing Market, By Country, 2021 - 2033 (USD Million)
Table 92. Latin America Infectious Disease Immunoassay Testing Market, By Disease Type, 2021 - 2033 (USD Million)
Table 93. Latin America Infectious Disease Immunoassay Testing Market, By Technology, 2021 - 2033 (USD Million)
Table 94. Latin America Infectious Disease Immunoassay Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 95. Latin America Infectious Disease Immunoassay Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 96. Brazil Infectious Disease Immunoassay Testing Market, By Disease Type, 2021 - 2033 (USD Million)
Table 97. Brazil Infectious Disease Immunoassay Testing Market, By Technology, 2021 - 2033 (USD Million)
Table 98. Brazil Infectious Disease Immunoassay Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 99. Brazil Infectious Disease Immunoassay Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 100. Argentina Infectious Disease Immunoassay Testing Market, By Disease Type, 2021 - 2033 (USD Million)
Table 101. Argentina Infectious Disease Immunoassay Testing Market, By Technology, 2021 - 2033 (USD Million)
Table 102. Argentina Infectious Disease Immunoassay Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 103. Argentina Infectious Disease Immunoassay Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 104. Middle East & Africa Infectious Disease Immunoassay Testing Market, By Country, 2021 - 2033 (USD Million)
Table 105. Middle East & Africa Infectious Disease Immunoassay Testing Market, By Disease Type, 2021 - 2033 (USD Million)
Table 106. Middle East & Africa Infectious Disease Immunoassay Testing Market, By Technology, 2021 - 2033 (USD Million)
Table 107. Middle East & Africa Infectious Disease Immunoassay Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 108. Middle East & Africa Infectious Disease Immunoassay Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 109. South Africa Infectious Disease Immunoassay Testing Market, By Disease Type, 2021 - 2033 (USD Million)
Table 110. South Africa Infectious Disease Immunoassay Testing Market, By Technology, 2021 - 2033 (USD Million)
Table 111. South Africa Infectious Disease Immunoassay Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 112. South Africa Infectious Disease Immunoassay Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 113. Saudi Arabia Infectious Disease Immunoassay Testing Market, By Disease Type, 2021 - 2033 (USD Million)
Table 114. Saudi Arabia Infectious Disease Immunoassay Testing Market, By Technology, 2021 - 2033 (USD Million)
Table 115. Saudi Arabia Infectious Disease Immunoassay Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 116. Saudi Arabia Infectious Disease Immunoassay Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 117. UAE Infectious Disease Immunoassay Testing Market, By Disease Type, 2021 - 2033 (USD Million)
Table 118. UAE Infectious Disease Immunoassay Testing Market, By Technology, 2021 - 2033 (USD Million)
Table 119. UAE Infectious Disease Immunoassay Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 120. UAE Infectious Disease Immunoassay Testing Market, By End Use, 2021 - 2033 (USD Million)
Table 121. Kuwait Infectious Disease Immunoassay Testing Market, By Disease Type, 2021 - 2033 (USD Million)
Table 122. Kuwait Infectious Disease Immunoassay Testing Market, By Technology, 2021 - 2033 (USD Million)
Table 123. Kuwait Infectious Disease Immunoassay Testing Market, By Test Type, 2021 - 2033 (USD Million)
Table 124. Kuwait Infectious Disease Immunoassay Testing Market, By End Use, 2021 - 2033 (USD Million)
List of Figures
Fig. 1 Infectious Disease Immunoassay Testing Segmentation
Fig. 2 Infectious Disease Immunoassay Testing Market Segmentation
Fig. 3 Market Research Process
Fig. 4 Data Triangulation Techniques
Fig. 5 Primary Research Pattern
Fig. 6 Market Research Approaches
Fig. 7 Value Chain Based Sizing & Forecasting
Fig. 8 QFD Modelling For Market Share Assessment
Fig. 9 Market Formulation & Validation
Fig. 10 Market Snapshot
Fig. 11 Disease Type And Technology Snapshot
Fig. 12 Technology And Test Type Snapshot
Fig. 13 Competitive Landscape Snapshot
Fig. 14 Market Dynamics
Fig. 15 Porter’s Five Forces Analysis
Fig. 16 PESTLE Analysis
Fig. 17 Infectious Disease Immunoassay Testing Market: Disease Type Outlook And Key Takeaways
Fig. 18 Infectious Disease Immunoassay Testing Market: Disease Type Movement Analysis
Fig. 19 Viral Infections Market Estimates And Forecast, 2021 - 2033 (USD Million)
Fig. 20 Bacterial Infections Market Estimates And Forecast, 2021 - 2033 (USD Million)
Fig. 21 Fungal Infections Market Estimates And Forecast, 2021 - 2033 (USD Million)
Fig. 22 Parasitic Infections Market Estimates And Forecast, 2021 - 2033 (USD Million)
Fig. 23 Infectious Disease Immunoassay Testing Market: Technology Outlook And Key Takeaways
Fig. 24 Infectious Disease Immunoassay Testing Market: Technology Movement Analysis
Fig. 25 ELISA Market Estimates And Forecast, 2021 - 2033 (USD Million)
Fig. 26 CLIA Market Estimates And Forecast, 2021 - 2033 (USD Million)
Fig. 27 Rapid Antigen Tests Market Estimates And Forecast, 2021 - 2033 (USD Million)
Fig. 28 Fluorescent Immunoassay Market Estimates And Forecast, 2021 - 2033 (USD Million)
Fig. 29 Multiplex Immunoassay Market Estimates And Forecast, 2021 - 2033 (USD Million)
Fig. 30 Infectious Disease Immunoassay Testing Market: Test Type Outlook And Key Takeaways
Fig. 31 Infectious Disease Immunoassay Testing Market: Method Movement Analysis
Fig. 32 Drug Discovery & Development Market Estimates And Forecast, 2021 - 2033 (USD Million)
Fig. 33 Antibody Testing Market Estimates And Forecast, 2021 - 2033 (USD Million)
Fig. 34 Combined Ag/Ab Tests Market Estimates And Forecast, 2021 - 2033 (USD Million)
Fig. 35 Toxin Assays Market Estimates And Forecast, 2021 - 2033 (USD Million)
Fig. 36 Infectious Disease Immunoassay Testing Market: End Use Outlook And Key Takeaways
Fig. 37 Infectious Disease Immunoassay Testing Market: End Use Movement Analysis
Fig. 38 Hospitals Market Estimates And Forecast, 2021 - 2033 (USD Million)
Fig. 39 Diagnostic Labs Market Estimates And Forecast, 2021 - 2033 (USD Million)
Fig. 40 Physician Offices Market Estimates And Forecast, 2021 - 2033 (USD Million)
Fig. 41 Blood Banks Market Estimates And Forecast, 2021 - 2033 (USD Million)
Fig. 42 Public Health Agencies Market Estimates And Forecast, 2021 - 2033 (USD Million)
Fig. 43 Infectious Disease Immunoassay Testing Revenue, By Region, 2025 & 2033 (USD Million)
Fig. 44 Regional Marketplace: Key Takeaways
Fig. 45 North America Infectious Disease Immunoassay Testing Estimates And Forecasts, 2021 - 2033 (USD Million)
Fig. 46 US Infectious Disease Immunoassay Testing Estimates And Forecasts, 2021 - 2033 (USD Million)
Fig. 47 Canada Infectious Disease Immunoassay Testing Estimates And Forecasts, 2021 - 2033 (USD Million)
Fig. 48 Mexico Infectious Disease Immunoassay Testing Estimates And Forecasts, 2021 - 2033 (USD Million)
Fig. 49 Europe Infectious Disease Immunoassay Testing Estimates And Forecasts, 2021 - 2033 (USD Million)
Fig. 50 UK Infectious Disease Immunoassay Testing Estimates And Forecasts, 2021 - 2033 (USD Million)
Fig. 51 Germany Infectious Disease Immunoassay Testing Estimates And Forecasts, 2021 - 2033 (USD Million)
Fig. 52 France Infectious Disease Immunoassay Testing Estimates And Forecasts, 2021 - 2033 (USD Million)
Fig. 53 Spain Infectious Disease Immunoassay Testing Estimates And Forecasts, 2021 - 2033 (USD Million)
Fig. 54 Italy Infectious Disease Immunoassay Testing Estimates And Forecasts, 2021 - 2033 (USD Million)
Fig. 55 Sweden Infectious Disease Immunoassay Testing Estimates And Forecasts, 2021 - 2033 (USD Million)
Fig. 56 Denmark Infectious Disease Immunoassay Testing Estimates And Forecasts, 2021 - 2033 (USD Million)
Fig. 57 Norway Infectious Disease Immunoassay Testing Estimates And Forecasts, 2021 - 2033 (USD Million)
Fig. 58 Rest Of Europe Infectious Disease Immunoassay Testing Estimates And Forecasts, 2021 - 2033 (USD Million)
Fig. 59 Asia Pacific Infectious Disease Immunoassay Testing Estimates And Forecast, 2021 - 2033 (USD Million)
Fig. 60 Japan Infectious Disease Immunoassay Testing Estimates And Forecast, 2021 - 2033 (USD Million)
Fig. 61 China Infectious Disease Immunoassay Testing Estimates And Forecast, 2021 - 2033 (USD Million)
Fig. 62 India Infectious Disease Immunoassay Testing Estimates And Forecast, 2021 - 2033 (USD Million)
Fig. 63 South Korea Infectious Disease Immunoassay Testing Estimates And Forecast, 2021 - 2033 (USD Million)
Fig. 64 Australia Infectious Disease Immunoassay Testing Estimates And Forecast, 2021 - 2033 (USD Million)
Fig. 65 Thailand Infectious Disease Immunoassay Testing Estimates And Forecast, 2021 - 2033 (USD Million)
Fig. 66 Rest Of Asia Pacific Infectious Disease Immunoassay Testing Estimates And Forecast, 2021 - 2033 (USD Million)
Fig. 67 Latin America Infectious Disease Immunoassay Testing Estimates And Forecasts, 2021 - 2033 (USD Million)
Fig. 68 Brazil Infectious Disease Immunoassay Testing Estimates And Forecasts, 2021 - 2033 (USD Million)
Fig. 69 Argentina Infectious Disease Immunoassay Testing Estimates And Forecasts, 2021 - 2033 (USD Million)
Fig. 70 Rest Of Latin America Infectious Disease Immunoassay Testing Estimates And Forecasts, 2021 - 2033 (USD Million)
Fig. 71 MEA Infectious Disease Immunoassay Testing Estimates And Forecasts, 2021 - 2033 (USD Million)
Fig. 72 South Africa Infectious Disease Immunoassay Testing Estimates And Forecasts, 2021 - 2033 (USD Million)
Fig. 73 Saudi Arabia Infectious Disease Immunoassay Testing Estimates And Forecasts, 2021 - 2033 (USD Million)
Fig. 74 UAE Infectious Disease Immunoassay Testing Estimates And Forecasts, 2021 - 2033 (USD Million)
Fig. 75 Kuwait Infectious Disease Immunoassay Testing Estimates And Forecasts, 2021 - 2033 (USD Million)
Fig. 76 Rest Of MEA Infectious Disease Immunoassay Testing Estimates And Forecasts, 2021 - 2033 (USD Million)
Fig. 77 Key Company Categorization
Fig. 78 Company Market Share
Fig. 79 Strategy Mapping

Companies Mentioned

  • Abbott
  • Siemens Healthineers
  • Danaher Corporation (Beckman Colter)
  • bioMerieux SA
  • Quidel Corporation
  • Sysmex Corporation
  • Ortho Clinical Diagnostics
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Becton, Dickinson, and Company
  • Thermo Fisher Scientific, Inc.

Table Information

Report AttributeDetails
No. of Pages150
PublishedMay 2026
Forecast Period2025 - 2033
Estimated Market Value ( USD ) in 2025 $ 8.89 Billion
Forecasted Market Value ( USD ) by 2033 $ 12.03 Billion
Compound Annual Growth Rate4.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Immunoassay Market Size, Share & Trends Analysis Report by Product, Technology, Application, End-use, Specimen, Region, and Segment Forecasts, 2026-2033 - Product Image

Immunoassay Market Size, Share & Trends Analysis Report by Product, Technology, Application, End-use, Specimen, Region, and Segment Forecasts, 2026-2033

  • Report
  • 190 Pages
  • Global
From
Middle East Diagnostic Reagents for Infectious Diseases Market Size, Share & Trends Analysis Report by Product (Molecular Reagents, Immunoassay Reagents), Disease Area, Technology, End Use, Country with Growth Forecasts, 2025-2033 - Product Image

Middle East Diagnostic Reagents for Infectious Diseases Market Size, Share & Trends Analysis Report by Product (Molecular Reagents, Immunoassay Reagents), Disease Area, Technology, End Use, Country with Growth Forecasts, 2025-2033

  • Report
  • 150 Pages
  • Middle East
From
Diagnostic Reagents for Infectious Diseases Market Size, Share & Trends Analysis Report by Product (Molecular Reagents, Immunoassay Reagents), Disease Area (Respiratory Infections, Enteric Infections), Technology, End Use and Region with Growth Forecasts, 2025-2033 - Product Image

Diagnostic Reagents for Infectious Diseases Market Size, Share & Trends Analysis Report by Product (Molecular Reagents, Immunoassay Reagents), Disease Area (Respiratory Infections, Enteric Infections), Technology, End Use and Region with Growth Forecasts, 2025-2033

  • Report
  • 150 Pages
  • Global
From
Enzyme Immunoassay Market Size, Share & Trends Analysis Report by Product (Reagents & Kits, Analyzers/Instruments, Software & Services), Application (Oncology, Cardiology, Endocrinology), Specimen, End Use, and Region with Growth Forecasts, 2025-2033 - Product Image

Enzyme Immunoassay Market Size, Share & Trends Analysis Report by Product (Reagents & Kits, Analyzers/Instruments, Software & Services), Application (Oncology, Cardiology, Endocrinology), Specimen, End Use, and Region with Growth Forecasts, 2025-2033

  • Report
  • 120 Pages
  • Global
From
U.S. Lateral Flow Assay Market Size, Share & Trends Analysis Report By Product (Kits & Reagents, Lateral Flow Readers), By Application (Veterinary Diagnostics, Food Safety & Environment Testing), By Technique, By End use, And Segment Forecasts, 2025 - 2033 - Product Image

U.S. Lateral Flow Assay Market Size, Share & Trends Analysis Report By Product (Kits & Reagents, Lateral Flow Readers), By Application (Veterinary Diagnostics, Food Safety & Environment Testing), By Technique, By End use, And Segment Forecasts, 2025 - 2033

  • Report
  • 100 Pages
  • United States
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.